Ovintiv price target raised to $59 from $57 at Truist
The Fly

Ovintiv price target raised to $59 from $57 at Truist

Truist analyst Neal Dingmann raised the firm’s price target on Ovintiv (OVV) to $59 from $57 and keeps a Buy rating on the shares. The firm is adjusting its model for Ovintiv after factoring in the announced accretive acquisition coupled with non-core sale, also agreeing with the company’s statement that the Permian and Montney remain two of the key North American oil basins with ample sub-$50/bbl breakevens, the analyst tells investors in a research note. The improved scale and strategic addition outweigh any downside related to investor concerns that Canadian assets could continue to garner a slight discount, the firm adds.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App